Citrate-mediated release of aurintricarboxylic acid from a calcium alginate complex: Implications for intravaginal HIV chemoprophylaxis and related applications

Pharmaceutical Development and Technology

Volumn 14, Issue 4, 2009, Pages 341-342

  Fong, Krystin ^a   Smith, Timothy J ^a  

^a UNIVERSITY OF THE PACIFIC   (United States)

Author keywords

Alginate; Aurintricarboxylic acid; Citrate

Indexed keywords

AURINTRICARBOXYLIC ACID; CALCIUM ALGINATE; CITRIC ACID;

ARTICLE; CHEMOPROPHYLAXIS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVAGINAL DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; PROSTATE FLUID;

ADMINISTRATION, INTRAVAGINAL; ALGINATES; ANTI-HIV AGENTS; AURINTRICARBOXYLIC ACID; CHEMISTRY, PHARMACEUTICAL; CITRATES; DRUG CARRIERS; GLUCURONIC ACID; HEXURONIC ACIDS; HIV INFECTIONS; SOLUBILITY;

EID: 70350657169     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.1080/10837450802585294     Document Type: Article

References (5)

1. Lagakos SW, Gable AR eds., Methodological Challenges in Biomedical HIV Prevention Trials. Washington DC: National Academies Press; 2008:37-68.
2. Kline EE, Treat EG, Averna TA, Davis MS, Smith AY, Sillerud LO. Citrate concentrations in human seminal fluid and expressed prostatic fluid determined via 1H nuclear magnetic resonance spectroscopy outperform prostate specific antigen in prostate cancer detection. J. Urol. 2006;176(5):2274-2279.
3. Smith TJ. Applications of chitosan and alginate in biotechnology. Curr. Top. Biotechnol. 2004;1:129-132.
4. Schols D, Baba M, Pauwels R, Desmyter J, De Clercq E. Specific interaction of aurintricarboxylic acid with the human immunodeficiency virus/CD4 cell receptor. PNAS. 1989;86:3322-3326.
5. Cushman M, Wang PL, Chang SH, Wild C, De Clercq E, Schols D, Goldman ME, Bowen JA. Preparation and anti-HIV activities of aurintricarboxylic acid fractions and analogues: direct correlation of antiviral potency with molecular weight. J. Med. Chem. 1991;34(1):329-337.